Before any new drug can be marketed, it must undergo a rigorous evaluation process conducted by the FDA. This includes a comprehensive review of toxicological data from preclinical and clinical studies. The FDA assesses the drugâs pharmacokinetics, pharmacodynamics, and potential adverse effects to determine its safety profile. Only after passing these evaluations does a drug receive approval for public use.
